GGrantIndex
← Search

DEVELOPMENT OF HEPATITIS C VIRUS-LIKE PARTICLES AS CANDIDATE HCV VACCINE

$70,936P51FY2007RRNIH

Texas Biomedical Research Institute, San Antonio TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →